News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,000 Results
Type
Article (88281)
Company Profile (812)
Press Release (785887)
Multimedia
Podcasts (213)
Webinars (34)
Section
Business (233382)
Career Advice (4153)
Deals (39902)
Drug Delivery (160)
Drug Development (91509)
Employer Resources (206)
FDA (18463)
Job Trends (17448)
News (398224)
Policy (40002)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3028)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (169)
Alliances (56982)
ALS (202)
Alzheimer's disease (1863)
Antibody-drug conjugate (ADC) (401)
Approvals (18670)
Artificial intelligence (713)
Autoimmune disease (233)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (214)
Biotechnology (486)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (720)
Cancer (5530)
Cardiovascular disease (490)
Career advice (3581)
Career pathing (45)
CAR-T (324)
CDC (68)
Celiac Disease (2)
Cell therapy (897)
Cervical cancer (42)
Clinical research (77664)
Collaboration (2018)
Company closure (6)
Compensation (1282)
Complete response letters (91)
COVID-19 (3010)
CRISPR (110)
C-suite (1012)
Cystic fibrosis (157)
Data (6998)
Decentralized trials (2)
Denatured (79)
Depression (173)
Diabetes (580)
Diagnostics (7378)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (347)
Drug pricing (233)
Drug shortages (36)
Duchenne muscular dystrophy (283)
Earnings (101061)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136232)
Executive appointments (1095)
FDA (21934)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1691)
Gene editing (237)
Generative AI (75)
Gene therapy (743)
GLP-1 (1190)
Government (5493)
Grass and pollen (8)
Guidances (395)
Healthcare (20996)
HIV (78)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (316)
Immuno-oncology (87)
Indications (149)
Infectious disease (3349)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (277)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (103)
Layoffs (666)
Leadership (44)
Legal (10169)
Liver cancer (102)
Longevity (26)
Lung cancer (737)
Lymphoma (406)
Machine learning (54)
Management (66)
Manufacturing (978)
MASH (190)
Medical device (15125)
Medtech (15203)
Mergers & acquisitions (23077)
Metabolic disorders (1554)
mRNA (211)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (418)
Neuropsychiatric disorders (112)
Neuroscience (3350)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (73)
Obesity (759)
Opinion (352)
Ovarian cancer (181)
Pain (242)
Pancreatic cancer (260)
Parkinson's disease (350)
Partnered (39)
Patents (566)
Patient recruitment (587)
Peanut (65)
People (67286)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23996)
Phase 2 (33705)
Phase 3 (25381)
Pipeline (6726)
Policy (368)
Postmarket research (3554)
Preclinical (10776)
Press Release (72)
Prostate cancer (284)
Psychedelics (61)
Radiopharmaceuticals (323)
Rare diseases (1073)
Real estate (7445)
Recruiting (81)
Regulatory (29506)
Reports (72)
Research institute (2752)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (21)
RSV (93)
Schizophrenia (168)
Series A (286)
Series B (209)
Service/supplier (30)
Sickle cell disease (111)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (50)
Startups (4344)
State (2)
Stomach cancer (21)
Supply chain (125)
Tariffs (101)
The Weekly (131)
Vaccines (1205)
Venture capital (106)
Weight loss (519)
Women's health (111)
Worklife (23)
Date
Today (140)
Last 7 days (607)
Last 30 days (3306)
Last 365 days (32848)
2026 (7328)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (96)
Alaska (7)
Arizona (363)
Arkansas (15)
Asia (51779)
Australia (9098)
California (12537)
Canada (3551)
China (1278)
Colorado (533)
Connecticut (551)
Delaware (375)
Europe (119216)
Florida (1866)
Georgia (406)
Hawaii (4)
Idaho (68)
Illinois (1054)
India (83)
Indiana (588)
Iowa (24)
Japan (483)
Kansas (136)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1556)
Massachusetts (9192)
Michigan (383)
Minnesota (706)
Mississippi (7)
Missouri (151)
Montana (37)
Nebraska (30)
Nevada (139)
New Hampshire (89)
New Jersey (3361)
New Mexico (33)
New York (3307)
North Carolina (1716)
North Dakota (10)
Northern California (6087)
Ohio (385)
Oklahoma (23)
Oregon (54)
Pennsylvania (2499)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (74)
South Dakota (1)
Southern California (4871)
Tennessee (200)
Texas (1991)
United States (45084)
Utah (378)
Vermont (1)
Virginia (318)
Washington D.C. (88)
Washington State (1034)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
There are 875,000 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
March 20, 2026
·
13 min read
Press Releases
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®
March 20, 2026
·
5 min read
Press Releases
Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program
March 20, 2026
·
2 min read
Press Releases
Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer’s candidate at AD/PD™ 2026
March 20, 2026
·
3 min read
Press Releases
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
March 20, 2026
·
6 min read
Press Releases
Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.
March 20, 2026
·
5 min read
Press Releases
GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer
March 20, 2026
·
1 min read
Press Releases
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at ECO 2026
March 20, 2026
·
5 min read
Press Releases
D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session
March 20, 2026
·
4 min read
Press Releases
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
March 20, 2026
·
2 min read
1 of 87,500
Next
